Furthermore, MALAT1 downregulates miR-34a expression level in melanoma cells and tumor specimens (Li et al., 2019), thereby it is a potential biomarker for many human cancer diagnosis as well as prognosis (Amodio et al., 2018; Li et al., 2018). Here, MALAT1 is linked to neoplasm.